These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9024869)

  • 21. Trypanosoma cruzi exoantigens: can those recognized by sera from chagasic patients trigger a protective immune response in mice?
    Gruppi A; Pistoresi-Palencia MC; Cerban F; Vottero-Cima E
    Res Immunol; 1991; 142(9):821-8. PubMed ID: 1796212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.
    Pellegrini A; Carrera-Silva EA; Arocena A; Cano RC; Aoki MP; Gea S
    Med Microbiol Immunol; 2011 Nov; 200(4):209-18. PubMed ID: 21431877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.
    Frank FM; Petray PB; Cazorla SI; Muñoz MC; Corral RS; Malchiodi EL
    Vaccine; 2003 Dec; 22(1):77-86. PubMed ID: 14604574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains.
    Martínez J; Campetella O; Frasch AC; Cazzulo JJ
    Immunol Lett; 1993 Feb; 35(2):191-6. PubMed ID: 7685319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma cruzi: immune response in mice immunized with parasite antigens.
    Rottenberg ME; Cardoni RL; deTitto EH; Moreno M; Segura EL
    Exp Parasitol; 1988 Feb; 65(1):101-8. PubMed ID: 2892694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.
    Pereira VR; Lorena VM; Nakazawa M; Luna CF; Silva ED; Ferreira AG; Krieger MA; Goldenberg S; Soares MB; Coutinho EM; Correa-Oliveira R; Gomes YM
    Parasitol Res; 2005 Jun; 96(3):154-61. PubMed ID: 15856302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG isotype profiles induced in mice by two Trypanosoma cruzi electronegative antigens.
    Cerban F; Gruppi A; Gea S; Vottero-Cima E
    Int Arch Allergy Appl Immunol; 1991; 96(1):35-40. PubMed ID: 1721610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
    Cerny N; Sánchez Alberti A; Bivona AE; De Marzi MC; Frank FM; Cazorla SI; Malchiodi EL
    Hum Vaccin Immunother; 2016; 12(2):438-50. PubMed ID: 26312947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
    Taibi A; Espinoza AG; Ouaissi A
    Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.
    Costa F; Franchin G; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM
    Vaccine; 1998 May; 16(8):768-74. PubMed ID: 9627933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.
    Basso B; Moretti ER; Vottero-Cima E
    Am J Trop Med Hyg; 1991 Apr; 44(4):413-9. PubMed ID: 1828328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease.
    Rowland EC; Mikhail KS; McCormick TS
    J Parasitol; 1992 Jun; 78(3):557-61. PubMed ID: 1375959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of the recombinant SAPA protein of Trypanosoma cruzi for mice.
    Nasser JR; Gómez LE; Sánchez D; Guerin M; Basombrío MA
    J Parasitol; 1997 Feb; 83(1):76-81. PubMed ID: 9057700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi: involvement of IgG isotypes in the parasitemia control of mice immunized with parasite exoantigens of isoelectric point 4.5.
    Cerban F; Gruppi A; Vottero-Cima E
    Exp Parasitol; 1992 Aug; 75(1):137-45. PubMed ID: 1639159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a recombinant Fab antibody fragment against cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
    Kaplan D; Baldi C; Chiaramonte MG; Fernandez MM; Levin MJ; Malchiodi E; Baldi A
    Biochem Biophys Res Commun; 1998 Dec; 253(1):53-8. PubMed ID: 9875219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypanosoma cruzi: IgG1 and IgG2b are the main immunoglobulins produced by vaccinated mice.
    Pyrrho AS; Moraes JL; Peçanha LM; Gattass CR
    Parasitol Res; 1998; 84(4):333-7. PubMed ID: 9569101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression.
    Guiñazú N; Pellegrini A; Carrera-Silva EA; Aoki MP; Cabanillas AM; Gìronés N; Fresno M; Cano R; Gea S
    Int J Parasitol; 2007 Sep; 37(11):1243-54. PubMed ID: 17512528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.